Travere Therapeutics (TVTX) Non Operating Income (2016 - 2025)
Historic Non Operating Income for Travere Therapeutics (TVTX) over the last 13 years, with Q3 2025 value amounting to $783000.0.
- Travere Therapeutics' Non Operating Income fell 4036.56% to $783000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.5 million, marking a year-over-year decrease of 16426.43%. This contributed to the annual value of -$3.3 million for FY2024, which is 12758.56% down from last year.
- Travere Therapeutics' Non Operating Income amounted to $783000.0 in Q3 2025, which was down 4036.56% from -$526000.0 recorded in Q2 2025.
- Travere Therapeutics' 5-year Non Operating Income high stood at $5.7 million for Q4 2023, and its period low was -$9.8 million during Q1 2022.
- Over the past 5 years, Travere Therapeutics' median Non Operating Income value was -$526000.0 (recorded in 2025), while the average stood at -$1.1 million.
- As far as peak fluctuations go, Travere Therapeutics' Non Operating Income soared by 40531.44% in 2023, and later crashed by 26770.63% in 2024.
- Travere Therapeutics' Non Operating Income (Quarter) stood at -$3.9 million in 2021, then soared by 128.8% to $1.1 million in 2022, then surged by 405.31% to $5.7 million in 2023, then plummeted by 209.34% to -$6.2 million in 2024, then skyrocketed by 112.55% to $783000.0 in 2025.
- Its Non Operating Income stands at $783000.0 for Q3 2025, versus -$526000.0 for Q2 2025 and $1.5 million for Q1 2025.